ClinicalTrials.Veeva

Menu

CAM in Hospice Palliative Care in Taiwan

T

Taipei Veterans General Hospital

Status

Completed

Conditions

Cancer

Treatments

Device: SSP treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT02663063
2015-10-005A

Details and patient eligibility

About

The study aims to explore the effects of silver spike point (SSP) treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients.

Full description

The study aims to explore the effects of silver spike point treatment on common symptoms including pain, breathlessness, nausea/vomiting, dry mouth etc. of terminal cancer patients. We will conducted a pilot study to evaluate the effects on different symptoms and then a prospective study will be conducted after validation of major effects.

Enrollment

60 patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cancer patients
  • Competent with clear consciousness
  • With symptoms of pain, breathlessness, nause/vomiting, dry mouth, generalized discomfort
  • Expected life span of at least 1 week

Exclusion criteria

  • With implanted devices
  • Not having clear consciousness
  • Expected life span less than 1 week
  • Foreigner

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

SSP treatment group
Experimental group
Description:
Case on SSP treatment
Treatment:
Device: SSP treatment
Non-SSP treatment group
Sham Comparator group
Description:
Sham SSP treatment
Treatment:
Device: SSP treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems